TCG Crossover GP II, LLC 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-01 5:29 pm Purchase | 2026-03-30 | 13G | VOR BIOPHARMA INC VOR | TCG Crossover GP II, LLC | 5,673,078 10.500% | 5,673,078 (New Position) | Filing |